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Abstract
Duchenne muscular dystrophy (DMD) is a neuromuscular disease that arises from mutations in the dystrophin-encoding
gene. Apart from muscle pathology, cognitive impairment, primarily of developmental origin, is also a significant
component of the disorder. Convergent lines of evidence point to an important role for dystrophin in regulating the
molecular machinery of central synapses. The clustering of neurotransmitter receptors at inhibitory synapses, thus
impacting on synaptic transmission, is of particular significance. However, less is known about the role of dystrophin in
influencing the precise expression patterns of proteins located within the pre- and postsynaptic elements of inhibitory
synapses. To this end, we exploited molecular markers of inhibitory synapses, interneurons and dystrophin-deficient mouse
models to explore the role of dystrophin in determining the stereotypical patterning of inhibitory connectivity within the
cellular networks of the hippocampus CA1 region. In tissue from wild-type (WT) mice, immunoreactivity of neuroligin2
(NL2), an adhesion molecule expressed exclusively in postsynaptic elements of inhibitory synapses, and the vesicular GABA
transporter (VGAT), a marker of GABAergic presynaptic elements, were predictably enriched in strata pyramidale and
lacunosum moleculare. In acute contrast, NL2 and VGAT immunoreactivity was relatively evenly distributed across all CA1
layers in dystrophin-deficient mice. Similar changes were evident with the cannabinoid receptor 1, vesicular glutamate
transporter 3, parvalbumin, somatostatin and the GABAA receptor alpha1 subunit. The data show that in the absence of
dystrophin, there is a rearrangement of the molecular machinery, which underlies the precise spatio-temporal pattern of
GABAergic synaptic transmission within the CA1 sub-field of the hippocampus.
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Introduction
Duchenne muscular dystrophy (DMD) [1] is a neuromuscular
disease that arises due to the absence of the protein dystrophin [2].
Dystrophin functions to provide a scaffold for the formation of a
complex of dystrophin-associated proteins (DAP), including
dystroglycan and syntrophin, which provide a link between the
cytoskeleton, cell membrane and extracellular matrix components
[3]. Disruption of this protein complex results in not only muscle
degeneration but also the added burden of non-progressive
cognitive impairment, which DMD patients suffer from, [1]
[4,5]. This impaired cognitive performance in DMD patients,
primarily of developmental origin, highlights the central role that
dystrophin contributes firstly to brain development as well as
coordinated neuronal activity in adulthood. However, the precise
pathological mechanisms underlying DMD-dependent cognitive
impairment are poorly understood.
This apparent multi-factorial role of dystrophin arises from its
complex expression patterns due to alternative promoter usage
and extensive alternative splicing, especially in brain [6–9]. As a
result, the brain contains the highest number of dystrophin
isoforms. Importantly, many of these dystrophin isoforms are
expressed in brain areas associated with cognitive functions.
Indeed, the expression patterns of dystrophins/DAP complexes
brain region and cell-type specific; CA pyramidal neurones
contain 427 kDa dystrophin and a1-syntrophin whereas dentate
granule cells have 71 kDa dystrophin and a2-syntrophin
[7,8,10,11]. These different dystrophin/DAP complexes assemble
at post-synaptic densities [12]. Alterations of the expression of
specific isoforms in hippocampal neurons in response to kainate
(Gorecki et al., 1998) and in sympathetic neurons following
axotomy (Zaccaria et al., 1998), as well as changes in synaptic
plasticity in dystrophic mdx mice (Vaillend et al., 1999) suggest
dystrophin involvement in assembly–disassembly and/or preser-
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vation of the postsynaptic apparatus. Moreover, b-dystroglycan is
a matrix metalloproteinase-9 substrate digested in response to
enhanced synaptic activity [13]. Increasing evidence points to
dystrophin/DAP complexes having a central role in regulating the
molecular machinery of synapses and thus having a central role in
synaptic transmission. A large body of work mainly using the mdx
mouse model of DMD indicates that the lack of dystrophin results
in a decrease in the synaptic quotient of GABA-A receptors
(GABAARs) [14], and altered GABAergic synaptic transmission
[15–18].
While the importance of dystrophin in contributing to the
anchoring of neurotransmitter receptors at post-synaptic densities
is unequivocal, its role in synapse formation has attracted less
attention. This is surprising given the fact that b-dystroglycan is a
physiological ligand for neurexins [19]. Neurexins and neuroligins
are synaptic cell-adhesion molecules that connect presynaptic and
postsynaptic neurons at synapses and thus occupy a central role in
synapse formation [20]. As such, any dystrophin-deficiency evoked
alterations in neurxin-neuroligin functions are likely to impact on
synapse formation. Such malformation of synapses will have a
dramatic effect in brain regions, which rely on the precise spatial
patterning of synaptic inputs for the coordinated network activity
underlying that brain region’s contribution to the cognitive
function. The importance of synapse location is exemplified in
the CA1 region of the hippocampus. Excitatory synapses on
individual CA1 pyramidal neurons are organised onto precise sub-
cellular dendritic domains located in either strata oriens, radiatum
or lacunosum moleculare, depending on the origins of their axons.
In contrast, GABAergic synaptic inputs onto individual pyramidal
neurons, arising from up to 21 functionally distinct inhibitory
interneurons [21], are preferentially targeted to perisomatic
pyramidal cell surfaces located in stratum pyramidale and to a
lesser extent, to dendritic surfaces in stratum lacunosum molecu-
lare. This precise stratification of functionally diverse synaptic
inputs onto distinct sub-cellular domains of individual pyramidal
cells is essential for the integration of the heterogeneous
information conveyed during synaptic transmission and thus a
prerequisite for the coordinated network activity occurring within
the hippocampus that underlies cognition. Recent evidence
indicates that inhibitory synapses on CA1 pyramidal neurons of
mdx mice undergo reorganisation [22]. In the current study, we
build on these finding by demonstrating that there is a cell-type
specific re-distribution of inhibitory inputs onto CA1 pyramidal
neurons in this mouse model of DMD.
Materials and Methods
All procedures involving experimental animals were performed
in accordance with the Animals (Scientific Procedures) Act, 1986
(UK) and associated procedures under Project License number
PPL 70/7094. Every effort was made to minimise any pain or
discomfort to the animals.
Animals
Three month old C57Bl/10, wild-type (WT), as well as Dmdmdx
(mdx) [23] and Dmd Gt(ROSAbgeo)1Mpd (mdxbgeo) [24] dystrophin-
mutant mice were used. The mdx lacks the full-length dystrophins
due to a point mutation in exon 23 while mdxbgeo is dystrophin-
null. Animals were maintained in a 12 h light/dark cycle and fed
normal diet and water ad libitum. A total of 8 mice from each
genotype were used for qualitative and quantitative analyses.
Tissue preparation
Animals were perfusion-fixed as follows: anaesthesia was
induced with isoflurane and maintained with pentobarbitone
(1.25 mg/kg of bodyweight; i.p.). The animals were perfused
transcardially with 0.9% saline solution for 1 minute, followed by
12 minutes with a fixative consisting of 1% paraformaldehyde,
15% v/v saturated picric acid, in 0.1 M phosphate buffer (PB),
pH 7.4. The brains were kept in the same fixative solution
overnight at 4uC. Coronal sections of the dorsal hippocampus,
60 mm thick, were prepared on a Vibratome and stored in 0.1 M
PB containing 0.05% sodium azide.
Immunohistochemical reactions
Immunohistochemical procedures were according to those used
in [25]. Five animals from each genotype were used to confirm the
native immunoreactivity patterns whilst three animals from each
genotype were used for quantitative analyses. A proteolytic antigen
retrieval method was used to localise membrane–bound epitopes
[26,27] for neurligin2 (NL2) and GABAAR alpha1 immunoreac-
tivity. Briefly, the tissue sections were incubated at 37uC for
10 minutes in 0.1 M PB followed by 15 minutes in 0.2 M HCl
containing 1 mg/ml pepsin (Sigma, UK) after which they were
washed thoroughly in Tris-buffered saline containing 0.3% triton
(TBS-Tx) for 30 minutes. Non-specific binding of secondary
antibodies was blocked by incubating sections with 20% normal
horse serum for 2 hours at room temperature. The tissue sections
were incubated with cocktails of primary antibodies diluted in
TBS-Tx, overnight at 4uC. See Table 1 for antibody details and
their specificity references. After washing with TBS-Tx, sections
were incubated in a mixture of appropriate secondary antibodies
conjugated with either Alexa Fluor 405 (Jackson ImmunoReser-
ach) Alexa Fluor 488 (Invitrogen, Eugene, OR), indocarbocyanine
(Cy3; Jackson ImmunoResearch), and indodicarbocyanine (Cy5;
Jackson ImmunoResearch), all diluted 1:1000, for 2 hours at room
temperature. Sections were washed in TBS-Tx and mounted in
Vectashield mounting medium (Vector Laboratories, Burlingame,
CA).
Image acquisition
Sections were examined with a confocal laser-scanning micro-
scope (LSM710; Zeiss, Oberkochen, Germany) using either a Plan
Apochromatic 20x DIC oil objective (NA0.8). a Plan Apochro-
matic 63x DIC oil objective (NA1.4) or a Plan Apochromatic 100x
DIC oil objective (NA1.46). Z-stacks were used for routine
evaluation of the labelling. All images shown represent a single
optical section. These images were obtained using sequential
acquisition of the different channels to avoid cross-talk between
fluorophores, with the pinholes adjusted to one airy unit for all
channels. Images were processed with the software Zen2008 Light
Edition (Zeiss, Oberkochen, Germany) and exported into Adobe
Photoshop. Only brightness and contrast were adjusted for the
whole frame, and no part of a frame was enhanced or modified in
any way.
Quantification of either the density of individual
immunoreactive clusters or the intensity of fluorescence
within the CA1 region of WT and dystrophin-deficient
mice
Our qualitative investigations revealed that most of the changes
in the immunoreactivity patterns manifested in strata pyramidale
and radiatum. Since these two layers of the hippocampus
represent the sites of predominantly inhibitory and excitatory
synaptic inputs, respectively, we restricted our quantifications to
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these layers in line with the focus of the study on the role of
dystrophin in influencing the location of synaptic inhibitory
marker proteins within defined hippocampal strata. Immunore-
activity for the voltage-gated potassium channel Kv2.1 was used to
delineate the somatic and proximal apical dendritic domains of
CA1 pyramidal neurons [28,29] and which are the conventional
locations for inhibitory synapses [30] and thus immunoreactivity
for proteins which are expressed within such populations of
synapses. The levels of immunoreactivity within such somato-
dendritic locations were compared to that within the distal region
of stratum radiatum, which contains almost exclusively excitatory
input [30] and predictably contains significantly lower levels of
immunoreactivity for inhibitory synaptic marker proteins.
The quantitative method used is according to [25]. For
immunoreactivity patterns which presented as individual clusters
(neuroligin2; vesicular glutamate transporter 3; GABAAR alpha1
subunit), the cluster density (number of clusters per mm2) was
determined. Immunoreactivity patterns for which individual
profiles were less distinct (VGAT; CB1, PV), densitometry of the
signal in the form of fluorescence intensity was determined. In all
cases, the perfusion fixation, reacting and imaging of tissue from
WT and dystrophin-deficient mice was performed under identical
conditions. For all quantitative analyses, a minimum of 3–5 tissue
sections per animals, 3 animals in total were used. The imaging
and quantification was performed as follows: within a tissue
section, 3 fields of view (FOV) were randomly selected within the
CA1 layer of interest. Z-stacks consisting of three optical sections
spaced 2 mm apart in the Z plane were acquired for each FOV.
The dimensions of each optical section were
85 mm685 mm61 mm in the X-Y-Z planes. Since the intention
was to compare the levels of immunoreactivity across the different
genotypes, raw, unprocessed images from the different genotypes,
obtained under identical imaging conditions, were used for
quantification purposes. Optimal imaging conditions were always
initially obtained using specimens from WT animals and then used
unchanged for those from mdx and mdxbgeo animals. Within an
optical section, the number of immunoreactive clusters was
manually counted or the total fluorescence intensity determined
as a measure of mean pixel intensity using ImageJ software. A
value for each FOV was obtained by computing the average from
the optical sections contained within a FOV. The means 6 SD
(cluster density or fluorescence intensity, arbitrary units, AU) for
all FOV between sections and between genotypes was compared
for statistical differences using Kruskal–Wallis one-way analysis of
variance. These values were then pooled since there were no
statistical differences (P.0.05) between the values for FOV
between sections and between animals for a particular genotype.
The average value from all FOVs and sections per animal were
computed for individual animals. This average value for an
individual animal was then considered an N of 1.
Quantification of the number of parvalbumin and
somatostatin-immunopositive cells within the CA1 sub-
field of WT and dystrophin-deficient mice
The method used was according to [31]. A minimum of 3 tissue
sections per animal, 3 animals in total were used. Using a 20x
objective and 0.6 digital zoom, fields of view (FOV) were acquired
across the entire CA1 region for a particular 60 mm-thick tissue
section. For each FOV, a Z-stack was obtained throughout the full
extent of the tissue section. The Z-stack consisted of optical
sections measuring 425 mm6425 mm in the X & Y planes and
5 mm in the Z plane. In all cases, signal for parvalbumin and
somatostatin was sequentially acquired using sequential acquisition
of the different channels with acquisition parameters identical for
all genotypes. The number of cells per tissue section and then the
average number per animal were determined. The mean 6 SEM
was then calculated for N= 3 WT, mdx and mdxbgeo animals.
Statistical analysis
All quantitative data are presented as the mean 6 SEM, unless
otherwise stated. The data were tested for normality using a
Shapiro-Wilk test. One-way analysis of variance (ANOVA) was
used to test for significant differences between the mean values
obtained for the 3 genotypes with a Tukey’s post-hoc test used to
assess differences between specific groups. In all cases, GraphPad
Prism6 was used for statistical analyses and the graphical
presentation of the data.
Table 1. Details of antibodies used in the study.
Primary antibodies Species (raised in) Source/code Dilution Specificity/reference
Cannabinoid receptor 1 guinea pig Frontier Science (Hokkaido,
Japan), # CB1-GP-Af530
1:3000 [64]
GABAAR alpha1 subunit rabbit Werner Sieghart, Antigen
sequence -a1N amino acids
1–9, Rabbit # 21/7, bleed
# 04/10/1999.
1:10000 [25]
Kv2.1 mouse Neuromab 1:1000 [65]
Neuroligin2 guinea pig Frontier Science
(Hokkaido, Japan),
# Nlgn2-GP-Af760
1:250 [66]
Parvalbumin goat Swant (Marly 1,
Switzerland) # PVG 214
1:2000 [67]
Somatostatin mouse GeneTex, # GTX71935 1:500 Labelling pattern as published
with other antibodies
VGAT Guinea-pig Synaptic Systems
# 131004
1:1000 [68]
VGLUT3 goat Frontier Science (Hokkaido, Japan),
# VGLuT3-Go-Af870
1:500 [39]
doi:10.1371/journal.pone.0108364.t001
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Figure 1. Localisation and quantification of NL2 immunoreactivity within the hippocampus of WT and dystrophin-deficient mice,
reacted and imaged under identical conditions. (A 1) shows the stereotypical pattern of NL2 immunoreactivity within the CA1 region of tissue
from WT animals. NL2 immunoreactivity is concentrated in strata pyramidale and lacunosum moleculare with considerably lower levels of signal in
stratum radiatum, particularly within the distal parts of this layer. In contrast, significantly lower levels of NL2 immunoreactivity were evident within
the stratum pyramidale of (B 1) mdx and (C 1) mdxbgeo mice. (A 2 i) shows immunoreactivity for KV2.1 within stratum pyramidale of WT tissue. Kv2.1 is
used to delineate the somato-dendritic plasma membranes and thus the major sites of inhibitory input onto pyramidal neurons. (A 2 ii, 3) shows that
that within this layer, NL2 immunoreactivity presented as individual clusters located exclusively on somato-dendritic cell surfaces. (B 2 i) and (C 2 i)
show that the level and pattern of Kv2.1 immunoreactivity within tissue from mdx and mdxbgeo mice respectively was indistinct to that of WT mouse.
This indicates that comparable fields of view and focal planes were selected for tissue from all genotypes. (B 2 ii, 3) and (C 2 ii, 3) demonstrate the
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significant decrease in the density of NL2 immunoreactive clusters within the stratum pyramidale of mdx and mdxbgeo tissue respectively. Numerous
cytoplasmically located NL2 immunopositive clusters were also evident in tissue from mdxbgeo mice (arrowheads) in comparison to WT in which
virtually all clusters were located on Kv2.1 immunopositive plasma membranes. (D 1) quantification of the density of NL2 immunoreactive clusters in
stratum pyramidale of WT, mdx and mdxbgeo tissue. (D 2) quantification of the density of NL2 immunoreactive clusters in the stratum radiatum of WT,
mdx and mdxbgeo tissue. Bars represent the means and lines the SEM. *P,0.05; ANOVA with Tukey’s posthoc test; N = 3 animals. Scale bars (A1, B1,
C1) 50 mm; (A2, B2, C2) 10 mm; (A3, B3, C3) 5 mm.
doi:10.1371/journal.pone.0108364.g001
Figure 2. Localisation and quantification of VGAT immunoreactivity within the hippocampus of WT and dystrophin-deficient mice,
reacted and imaged under identical conditions. (A) shows the pattern of VGAT immunoreactivity within the hippocampus of WT mouse tissue.
(A 1) an overview of the entire hippocampus demonstrating the prototypical enrichment of VGAT immunoreactivity within the cell body regions of
the hippocampus. (A 2) a magnified view of the CA1 sub-field confirming the enrichment of VGAT immunoreactivity in stratum pyramidale compared
with the dendritic regions. (A 3) is magnified view of stratum radiatum showing the comparatively sparse level of VGAT immunoreactivity within this
layer in WT mice. (B) and (C) show the pattern of VGAT immunoreactivity within the hippocampus of mdx and mdxbgeo mouse tissue respectively,
reacted and imaged under conditions identical to those for WT tissue. Whilst the enrichment within (B 2, C 2) stratum pyramidale is still evident, the
level of signal is significantly lower compared to WT. There is also a noticeably higher level VGAT immunoreactivity within (B 3, C 3) stratum radiatum
compared to WT. (D 1) quantification of the intensity of VGAT immunoreactivity within stratum pyramidale of WT, mdx and mdxbgeo tissue. (D 2)
quantification of the intensity of VGAT immunoreactivity in the stratum radiatum of WT, mdx and mdxbgeo tissue. Bars represent the means and lines
the SEM. *P,0.05; ANOVA with Tukey’s posthoc test; N = 3 animals. Scale bars (A1, B1, C1) 200 mm; (A2, B2, C2) 40 mm; (A3, B3, C3) 20 mm.
doi:10.1371/journal.pone.0108364.g002
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Results
In this study, we exploited molecular markers of pre- and
postsynaptic elements as well specific interneuron sub-classes to
investigate the potential role of dystrophin in influencing the
location of putative inhibitory synapses within specific layers of the
CA1 region of the hippocampus.
Altered distribution of the postsynaptic marker protein
neuroligin2 (NL2) in the CA1 region of the hippocampus
As a start, we used NL2 immunoreactivity to investigate the
distribution of putative inhibitory synapses in the CA1 region of
WT and dystrophin-deficient mice. NL2 is exclusively localised to
inhibitory synapses [32] and functions in the assembly of the
postsynaptic apparatus in inhibitory synapses [33,34]. The
majority of inhibitory synapses on CA1 pyramidal neurons are
located perisomatically [30]. In accordance, NL2 within the CA1
region of the hippocampus from WT mice has been shown to be
enriched in stratum pyramidale [31] indicating that NL2
immunoreactivity is predictive of the location of inhibitory
synapses within this brain region. In tissue from WT mice, NL2
immunoreactivity was predictably enriched within stratum pyrami-
dale with lower levels of immunoreactivity evident in strata oriens,
radiatum and lacunosum moleculare (Fig. 1 A1). In stratum
radiatum, a distinct gradient was noticeable with most of the
signal concentrated within the proximal regions of this layer,
decreasing to negligible amounts in the distal regions. This varying
parcelation of NL2 immunoreactivity into distinct layers closely
follows the distribution of inhibitory synapses within this brain
region [30]. High resolution inspection of NL2 immunoreactivity
confirmed that within stratum pyramidale, the signal presented as
individual clusters located on the plasma membranes of somata
Figure 3. Localisation and quantification of CB1 immunoreactivity within the hippocampus of WT and dystrophin-deficient mice,
reacted and imaged under identical conditions. (A) shows the pattern of CB1 immunoreactivity within the hippocampus of WT mouse tissue.
(A 1) an overview of the entire hippocampus demonstrating the prototypical enrichment of VGAT immunoreactivity within the cell body regions of
the hippocampus compared to one of the dendritic regions (arrow). (A 2) a magnified view of the CA1 sub-field confirming the enrichment of CB1
immunoreactivity in stratum pyramidale compared with the dendritic regions. (B) and (C) show the pattern of CB1 immunoreactivity within the
hippocampus of mdx and mdxbgeo mouse tissue respectively, reacted and imaged under conditions identical to those for the WT tissue. Note the
significant level of signal within the dendritic layers, particularly in mdxbgeo mouse tissue (arrow). Whilst the enrichment within (B 2, C 2) stratum
pyramidale is still evident, the level of signal is significantly lower compared to WT. (D 1) quantification of the intensity of CB1 immunoreactivity
within stratum pyramidale of WT, mdx and mdxbgeo tissue. (D 2) quantification of the intensity of CB1 immunoreactivity in the stratum radiatum of
WT, mdx and mdxbgeo tissue. Bars represent the means and lines the SEM. *P,0.05; ANOVA with Tukey’s posthoc test; N = 3 animals. Scale bars (A1,
B1, C1) 200 mm; (A2, B2, C2) 40 mm.
doi:10.1371/journal.pone.0108364.g003
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and proximal apical dendritic profiles, delineated by Kv2.1
immunoreactivity (Fig. 1 A2, 3). In tissue from mdx mice reacted
and imaged under conditions identical to those used for the WT
tissue, the characteristic enrichment of NL2 labelling pattern
within stratum pyramidale evident in the WT tissue was less
striking. Instead, diffuse signal within this layer closely matched the
intensity of signal in stratum radiatum. In contrast, the density of
NL2 with stratum lacunosum moleculare appeared similar to levels
in the tissue from WT (Fig. 1 B). This suggests that the influence of
dystrophin on the location of NL2 immunoreactivity is specific to
strata pyramidale and radiatum. The apparent redistribution of
NL2 immunoreactivity within the CA1 sub-field in dystrophin-
deficient mice was most pronounced in tissue from our mdxbgeo
mouse model (lacking all dystrophins) where no apparent gradient
in labelling intensity between strata was evident (Fig. 1 C).
Quantification of NL2 immunoreactivity revealed a significant
Figure 4. Localisation and quantification of VGLUT3 immunoreactivity within the hippocampus of WT and dystrophin-deficient
mice, reacted and imaged under identical conditions. (A) shows the pattern of VGLUT3 immunoreactivity within the hippocampus of WT
mouse tissue. (A 1) an overview of the entire hippocampus demonstrating the prototypical enrichment of VGLUT3 immunoreactivity within the cell
body regions of the hippocampus with lower levels evident in distal dendritic layers. (A 2 i) and (A 2 ii) shows puncta immunoreactive for VGLUT3 and
CB1 respectively on Kv2.1 immunopositive somato-dendritic profiles within stratum pyramidale. (A 2 iii) shows that virtually all VGLUT3
immunopositive puncta colocalise with those immunopositive for CB1 and are thus likely to represent the axon terminals of cholecystokinin-
expressing basket cells. (B) and (C) show the pattern of VGLUT3 immunoreactivity within the hippocampus of mdx and mdxbgeo mouse tissue
respectively, reacted and imaged under conditions identical to those for the WT tissue. (B 2 I, ii) and (C 2 I, ii) demonstrate the significantly lower
levels of VGLUT3 and CB1 immunoreactivity within the stratum pyramidale of mdx and mdxbgeo mouse tissue respectively. (B 2 iii) and (C 2 iii)
demonstrate the sparse number of colocalised VGLUT3 and CB1 immunoreactive clusters suggestive of a significant decrease in the density of
innervation by cholecystokinin-expressing basket cells within this region of dystrophin-deficient mice. (D) quantification of the density of VGLUT3
immunoreactive clusters in stratum pyramidale of WT, mdx and mdxbgeo tissue. Bars represent the means and lines the SEM. *P,0.05; ANOVA with
Tukey’s posthoc test; N = 3 animals. Scale bars (A, B, C, 1) 200 mm; (A, B, C, 2 i, ii) 10 mm; (A, B, C, 2 iii) 5 mm.
doi:10.1371/journal.pone.0108364.g004
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Figure 5. Localisation and quantification of PV and somatostatin immunoreactivity within the hippocampus of WT and dystrophin-
deficient mice, reacted and imaged under identical conditions. (A 1), (A 2) and (A 3) show PV immunoreactivity within the CA1 region of WT,
mdx and mdxbgeo tissue respectively. Note the significant increase in the level of PV immunoreactivity within stratum radiatum of mdx tissue. (B 1), (B
2) and (B 3) show somatostatin immunoreactivity within the CA1 region of WT, mdx and mdxbgeo tissue respectively. Note the significantly increase in
the level of somatostatin immunoreactivity particularly within stratum radiatum of mdx tissue. Images in (C) are overlays of (A) and (B). Note the
significant number of PV-somatostatin co-expressing neurons in (C 2) tissue from mdx mice. (D 1) quantification of the intensity of PV
Location of Hippocampal Synaptic Proteins in the Absence of Dystrophin
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decrease in the density of NL2 immunoreactive clusters within
stratum pyramidale of dystrophin-deficient mice compared to WT
mice (mean 6 SEM; WT 1561 clusters per 100 mm2, mdx 1061
clusters per 100 mm2, mdxbgeo 1061 clusters per 100 mm2; P,
0.0001, ANOVA, N=3 animals per genotype) (Fig. 1 D1) with a
significant increase in density evident within the distal stratum
radiatum (mean 6 SEM; WT 561 clusters per 100 mm2, mdx
761 clusters per 100 mm2, mdxbgeo 961 clusters per 100 mm2; P,
0.0001, ANOVA, N=3 animals per genotype) (Fig. 1 D2).
Collectively, the data indicate that the deletion of dystrophin
impacts on the location of NL2 expression which suggests the
formation of misplaced inhibitory synapses within the CA1 region
of the mouse hippocampus.
Immunoreactivity for the GABAergic axonal terminal
marker protein vesicular GABA transporter (VGAT)
mirrors the changes in NL2 expression in the absence of
dystrophin
We exploited the immunoreactivity pattern of the vesicular
GABA transporter (VGAT) to investigate whether the distribution
of GABAergic innervation in the CA1 sub-field of WT and
dystrophin-deficient mice mirrored the altered pattern of putative
inhibitory synapses inferred by the changed NL2 immunoreactiv-
ity. In tissue fromWT mice, predictably, VGAT immunoreactivity
was enriched in strata pyramidale and lacunosum moleculare with
a significantly lower level of expression in strata oriens and
radiatum (Fig. 2 A 1–3). In tissue from mdx mice, VGAT signal
was still concentrated in strata pyramidale and lacunosum
moleculare compared to other layers, although it was at lower
levels when compared to the signal in WT tissue (Fig. 2 B1).
However, higher levels of VGAT immunoreactivity were evident
in stratum radiatum of mdx tissue when compared to the level of
signal within this layer of the WT tissue (Fig. 2 B2, 3). This trend
towards a relatively even distribution of VGAT immunoreactivity
across strata pyramidale and radiatum was most striking in tissue
from mdxbgeo mice (Fig. 2 C). Quantification of VGAT immuno-
fluorescence intensity in stratum pyramidale confirmed a signifi-
cant decrease in the intensity of the signal in mdx and mdxbgeo
mice compared to WT mice (mean 6 SEM in arbitrary units, AU;
WT 6062 AU, mdx 4863 AU, mdxbgeo 4862 AU; P,0.0001,
ANOVA, N=3 animals per genotype) (Fig. 2 D1). In contrast,
there was a significant increase in the intensity of VGAT
immunoreactivity signal in stratum radiatum of mdx and mdxbgeo
mice compared to WT mice (mean 6 SEM in arbitrary units, AU;
WT 1461 AU, mdx 1661 AU, mdxbgeo 1661 AU; P,0.0001,
ANOVA, N=3 animals per genotype) (Fig. 2 D2). Collectively,
the redistribution of NL2 and VGAT immunoreactivity from
strata pyramidale to radiatum in mdx and mdxbgeo mice suggests
that dystrophin is associated with the patterning of GABAergic
innervation in the mouse CA1 sub-field. Thus, dystrophin appears
to be essential for the stereotypical expression patterning of both
pre- and postsynaptic proteins associated with GABAergic
transmission within the CA1 region of the hippocampus. If so,
this is likely to manifest in an alteration in the location of putative
GABA release sites within the region. To verify this, we examined
the well-described axonal targeting patterns of interneurons, which
provide the major source of GABA within this region.
The absence of dystrophin alters the location of proteins
located within the axons of specific classes of
interneurons
Numerous functionally and neurochemically distinct types of
interneurons preferentially innervate specific sub-cellular domains
of CA1 pyramidal cells [21,35]. Since the above data suggest an
apparent redistribution of inhibitory pre- and postsynaptic
molecular markers between strata pyramidale and radiatum, we
investigated whether this altered pattern of inhibitory innervation
may be reflected within the axonal projections of specific classes of
interneuron. Axon terminals innervating the perisomatic domains
of CA1 pyramidal neurons arise exclusively from two broad classes
of basket cells identified by their expression of either the calcium
binding protein parvalbumin (PV) [36] or the neuropeptide
cholecystokinin (CCK) [37]. The majority of CCK-expressing
basket cells also express the cannabinoid receptor 1 (CB1) in their
axon terminals [38]. We therefore investigated the distribution of
CB1 immunoreactivity within the CA1 sub-field. CB1 signal was
characteristically enriched within stratum pyramidale of the tissue
from WT mice (Fig. 3 A1) with significantly lower levels in stratum
radiatum (Fig. 3 A2). In comparison, there was a noticeable
decrease in the intensity of CB1 immunoreactivity in stratum
pyramidale of this tissue from mdx mice, reacted and imaged
under conditions identical to those used for WT samples (Fig. 3
B1), although there was still an apparent gradient in the signal
within stratum radiatum (Fig. 3 B2). The dramatic decrease in the
intensity of CB1 immunoreactivity in stratum pyramidale was most
pronounced in tissue from mdxbgeo mice (Fig. 3 C1), in which,
comparatively more intense CB1 signal was evident in stratum
radiatum (Fig. 3 C2). Quantification of the intensity of CB1
immunoreactivity confirmed a significant decrease in the levels of
CB1 staining in the stratum pyramidale of dystrophin-deficient
mice (mean 6 SEM in arbitrary units, AU; WT 11469 AU, mdx
4465 AU, mdxbgeo 3463 AU; P,0.0001, ANOVA, N=3
animals per genotype) (Fig. 3 D1). Interestingly, while in WT
mice, the intensity of staining in stratum radiatum was predictably
less than that in stratum pyramidale, signal within the stratum
radiatum of mdxbgeo was significantly more than that in the
stratum pyramidale of this genotype, but still significantly less than
that in WT (mean 6 SEM in arbitrary units, AU; WT 4463 AU,
mdx 3264 AU, mdxbgeo 3863 AU; P,0.0001, ANOVA, N=3
animals per genotype) (Fig. 3 D2).
We next used an additional marker of CCK-expressing basket
cell axon terminals, namely the vesicular glutamate transporter 3
(VGLUT3) [39], in order to verify the potential changes in this
population of axonal projections in the absence of dystrophin. In
tissue from WT mice, VGLUT3 immunoreactivity was charac-
teristically enriched within stratum pyramidale and to a lesser
degree in stratum lacunosum moleculare (Fig. 4 A1). High
resolution visualisation revealed that within stratum pyramidale,
individual VGLUT3 immunoreactive clusters contacted the
somatic and proximal dendritic compartments of KV2.1 im-
munopositive neurons (Fig. 4 A2i). Co-labelling with CB1 (Fig. 4
A2iii) showed complete colocalisation with VGLUT3 immunopo-
sitive clusters (Fig. 4 A2iii) indicating that these VGLUT3
immunopositive clusters are likely to represent axon terminals of
CCK-expressing basket cells. In concordance with CB1 and
VGAT immunoreactivity profiles, there was a striking decrease in
the intensity of the VGLUT3 signal in the stratum pyramidale of
immunoreactivity within stratum pyramidale of WT, mdx and mdxbgeo tissue. (D 2) quantification of the intensity of PV immunoreactivity in the
stratum radiatum of WT, mdx and mdxbgeo tissue. Bars represent the means and lines the SEM. *P,0.05; ANOVA with Tukey’s posthoc test; N = 3
animals. Scale bar 50 mm.
doi:10.1371/journal.pone.0108364.g005
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mdx tissue and to a lesser extent in stratum lacunosum moleculare
(Fig. 4 B1). In comparison to WT tissue, sparse VGLUT3
immunoreactive clusters contacted Kv2.1 immunoreactive somata
and dendrites in stratum pyramidale and colocalised with CB1
immunoreactive puncta (Fig. 4 B2). This decreased intensity in
VGLUT3 immunoreactivity in the absence of dystrophin was
mirrored in tissue from mdxbgeo mice (Fig. 4 C). Quantification of
the density of VGLUT3 immunoreactive clusters within the
stratum pyramidale confirmed the significant decrease in dystro-
phin-deficient mice compared to WT (mean 6 SEM; WT 1761
clusters per 1000 mm2, mdx 1061 clusters per 1000 mm2, mdxbgeo
1061 clusters per 1000 mm2; P,0.0001, ANOVA, N=3 animals
per genotype) (Fig. 4 D). The implication is that dystrophin
expression within CA1 pyramidal neurons is essential for the
targeting of CCK-expressing basket cell axons to the precise
perisomatic domains of pyramidal neurons.
Apart from CCK-expressing basket cells, parvalbumin (PV)-
containing basket cells provide the remaining inhibitory input onto
somatic and proximal dendritic domains of CA1 pyramidal cells.
We therefore explored the pattern of PV immunoreactivity in the
CA1 sub-field of WT and dystrophin-deficient mice. In tissue from
WT mice, PV immunoreactivity was characteristically concen-
trated in axonal profiles preferentially located in stratum pyrami-
dale with signal also evident in isolated somata located in strata
oriens and radiatum (Fig. 5 A1). In tissue from mdx mice, there
was no discernible difference in the intensity of PV immunoreac-
tivity within stratum pyramidale. However, PV immunoreactivity
within dendritic layers such as strata oriens and radiatum
appeared elevated compared to these corresponding layers in
WT tissue (Fig. 5 A2). In contrast, PV immunoreactivity profile
within tissue from mdxbgeo mice appeared indistinct to that of WT
tissue (Fig. 5 A3).
Intriguingly, an increase in the number of PV-expressing
neurons has been reported in the hippocampus of mdx mice
[40], however, it is not clear which particular sub-population of
PV-expressing interneurons is reflected in this increased density. In
the hippocampus, interneurons termed bistratified cells express
both PV and somatostatin, and project their axons preferentially
to dendritic regions [41], that is the location of elevated PV signal
in mdx mice. We therefore investigated the pattern of somatostatin
immunoreactivity in order to elucidate the possible source of the
more widespread PV innervation within dendritic layers. In tissue
from WT mice, somatic immunoreactivity for somatostatin was
evident primarily in strata oriens and pyramidale with immuno-
reactive varicosities distributed throughout strata oriens, radiatum
and lacunosum moleculare (Fig. 5 B1). In mdx tissue, the pattern of
somatostatin signal was markedly increased compared to WT with
a higher level of immunoreactivity across dendritic layers of the
CA1 sub-field (Fig. 5 B2). Somatostatin immunoreactivity in tissue
from mdxbgeo mice appeared less intense than that in mdx tissue
but was also evenly distributed across CA1 strata (Fig. 5 B3).
Putative bistratified interneurons, identified by their co-expression
of both PV and somatostatin, were evident in all genotypes, but
were particularly noticeable in tissue from mdx mice (Fig. 5 C1–3).
Quantification of the intensity of PV immunoreactivity revealed
that within stratum pyramidale, there were no significant
differences across genotypes (mean 6 SEM in arbitrary units,
AU; WT 6163 AU, mdx 6163 AU, mdxbgeo 6063 AU; P=0.4,
ANOVA, N=3 animals per genotype) (Fig. 5 D1). However,
within stratum radiatum, the intensity of PV immunoreactivity in
tissue from mdx mice was significantly higher than that of WT and
mdxbgeo mice (mean 6 SEM in arbitrary units, AU; WT 3863
AU, mdx 5062 AU, mdxbgeo 3764 AU; P,0.0001, ANOVA,
N=3 animals per genotype) (Fig. 5 D2). Collectively, these data
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suggest more widespread innervation in dystrophin-deficient mice
by those PV-containing interneurons, which preferentially target
dendritic domains of pyramidal neurons; these are likely to be PV-
somatostatin co-expressing bistratified neurons. To assess whether
the increased levels of immunoreactivity of these neurochemicals
(PV, somatostatin) within mdx mice might be a manifestation of
either increased PV, somatostatin, or PV-somatostatin (that is,
bistratified cells) cell density, we counted the number of PV,
somatostatin and PV-somatostatin expressing neurons within
strata oriens, pyramidale and radiatum in WT, mdx and mdxbgeo
mice. We detected a significant increase the number of PV,
somatostatin and PV-somatostatin expressing neurons in tissue
from mdx mice throughout all layers of the CA1 region whilst
higher numbers of such immunopositive neurons were also evident
in the stratum radiatum of mdxbgeo tissue, when compared with
tissue from WT mice (Table 2). Collectively, the data suggest that
the absence of dystrophin profoundly affects the expression pattern
of somatostatin within this brain region. It should be noted that
within this brain region, somatostatin is also expressed by O-LM
cells [42,43] and hippocamposeptal neurons [44] but these cells do
Figure 6. Localisation and quantification of GABAAR alpha1 subunit immunoreactivity within the CA1 region of the hippocampus
of WT and dystrophin-deficient mice, reacted and imaged under identical conditions. (A 1) shows that, in WT tissue, alpha1 subunit
immunoreactivity is enriched within the dendritic layers of strata oriens and radiatum with comparatively lower levels evident in strata pyramidale and
lacunosum moleculare. (A 2) shows that within stratum pyramidale, the majority of alpha1 subunit immunoreactive clusters colocalise with clusters
immunopositive for NL2 on Kv2.1 somato-dendritic cell surfaces. (B 1) shows that within the CA1 region of mdx mice, there is an apparent increase in
the intensity of alpha1 subunit immunoreactivity within strata oriens and radiatum when compared to WT. (B 2) shows that within stratum
pyramidale, there is comparatively less colocalisation between alpha1 subunit and NL2 immunopositive clusters. (C 1) shows that within the CA1
region of mdxbgeo mice, there is a striking decrease in the intensity of alpha1 subunit immunoreactivity throughout all layers when compared to WT.
Accordingly, (C 2) shows that there is significantly less colocalisation between alpha1 subunit and NL2 immunopositive clusters when compared to
WT. (D 1) quantification of the intensity of alpha1 subunit immunoreactivity within stratum radiatum of WT, mdx and mdxbgeo tissue. (D 2)
quantification of the density of alpha1 subunit immunoreactive clusters in stratum pyramidale of WT, mdx and mdxbgeo tissue. (D 3) quantification of
the density of alpha1 subunit immunoreactive clusters colocalised with clusters immunoreactive for NL2 in stratum pyramidale of WT, mdx and
mdxbgeo tissue. Bars represent the means and lines the SEM. *P,0.05; ANOVA with Tukey’s posthoc test; N = 3 animals. Scale bars (A, B, C, 1) 50 mm;
(A, B, C, 2) 5 mm.
doi:10.1371/journal.pone.0108364.g006
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not co-express PV. Functional studies in which the recorded cells
are labelled and unequivocally identified [43,45] would thus be
required to determine which particular interneuron-type exhibits
altered projection patterns in the absence of dystrophin.
Altered distribution and synaptic clustering of the GABA-
A receptor (GABAAR) alpha1 subunit in dystrophin-
deficient mice
The data above indicate alterations in the stereotypical
projection patterns of GABAergic axons in the CA1 sub-field. If
so, this altered release of GABA within different strata is likely to
require a parallel change in the expression pattern of GABA
receptors required to mediate the effects of this neurotransmitter
within this region. To examine this, we focused on GABAARs, and
in particular, the most abundant subtype in the brain, namely
those containing the alpha1 subunit [46]. The distribution of
GABAAR alpha1 subunit immunoreactivity in the CA1 region of
the WT mice was similar to that previously reported [47,48], being
concentrated in strata oriens and radiatum with lower levels in
stratum pyramidale (Fig. 6 A1). The level of GABAAR alpha1
subunit immunoreactivity was noticeably higher in strata oriens
and radiatum of mdx tissue (Fig. 6 B1). However, in stark contrast,
the level of GABAAR alpha1 subunit immunoreactivity in mdx
bgeo
mice was significantly lower than that of WT and mdx across all
layers (Fig. 6 C1). Quantification of the intensity of GABAAR
alpha1 subunit immunoreactivity within stratum radiatum con-
firmed a significant increase in mdx tissue whilst the levels in tissue
from mdxbgeo mice was significantly lower, compared to WT tissue
(mean 6 SEM in arbitrary units, AU; WT 11362 AU, mdx
12262 AU, mdxbgeo 6462 AU; P,0.0001, ANOVA, N=3
animals per genotype) (Fig. 6 D1).
These divergent levels of GABAAR alpha1 subunit immunore-
activity within the dendritic layers of the CA1 region were
accompanied by altered levels of colocalisation with NL2
immunopositive clusters within stratum pyramidale. In tissue from
WT mice, virtually all NL2 immunoreactive clusters co-localised
with those of the GABAAR alpha1 subunit in stratum pyramidale
suggesting that the majority of inhibitory synapses within this
layer, presumably located on pyramidal somata, expressed alpha1
subunit-containing GABAARs (Fig. 6 A2), in agreement with
previously published evidence [49]. However, in tissue from mdx
and mdxbgeo mice, only sparse co-localisation between NL2 and
GABAAR alpha1 subunit immunoreactive clusters was evident
(Fig. 6 B2, C2). A reason for the low degree of GABAAR alpha1
subunit colocalisation with NL2 could be the significant decrease
in the density of NL2 immunoreactive clusters in dystrophin-
deficient mice (Fig. 1) or a decrease in the density of GABAAR
alpha1 subunit expression. To determine this, we quantified the
density of GABAAR alpha1 subunit immunoreactive clusters, as
well as the density of NL2- GABAAR alpha1 subunit colocalised
clusters. There were no significant differences in the density of
GABAAR alpha1 subunit immunoreactive clusters within stratum
pyramidale of WT and mdx mice, although the density within
mdxbgeo was significantly lower than both WT and mdx (mean 6
SEM; WT 9262 clusters per 100 mm2, mdx 9561 clusters per
100 mm2, mdxbgeo 5461 clusters per 100 mm2; P,0.0001,
ANOVA, N=3 animals per genotype) (Fig. 4 d2). However,
there was a significant decrease in the density of NL2- GABAAR
alpha1 subunit colocalised clusters in both mdx and mdxbgeo tissue
(mean 6 SEM; WT 7262 clusters per 100 mm2, mdx 5461
clusters per 100 mm2, mdxbgeo 4461 clusters per 100 mm2; P,
0.0001, ANOVA, N=3 animals per genotype) (Fig. 4 D2).
Collectively, the data suggest changes in the patterns of GABAAR
alpha1 subunit immunoreactivity which mirror those of inhibitory
synaptic marker proteins within this brain region.
Discussion
The current study shows that the mouse models in which
dystrophin is constitutively deleted present with a complex pattern
of alterations in the location of proteins associated with both the
pre- and postsynaptic elements of inhibitory synapses as well as
those proteins located in the axon terminals of specific GABAergic
interneuron classes. The data suggest that in the absence of
dystrophin, there is a rearrangement of the molecular machinery
which underlies the precise spatio-temporal pattern of GABAergic
synaptic transmission within the CA1 sub-field of the hippocam-
pus. This could lead to an imbalance in the exquisite choreog-
raphy of cellular network activity that underlies salient aspects of
hippocampal function such as learning and memory, thereby
contributing to the cognitive impairment associated with dystro-
phin-mutations leading to DMD.
Alterations in the density and location of pre- and post-
synaptic inhibitory marker proteins
Coordinated brain activity relies on the rhythmic activity of
functionally distinct cell-types operating within strict spatio-
temporal constraints [43]. Central to such optimal cellular
communication, and thus coordinated neuronal activity between
ensembles of neuronal networks, is the precise patterning of
inhibitory and excitatory synaptic connections between neuronal
classes [50,51]. The relationship between the type of synapse and
their sub-cellular location has been best characterised in the CA1
sub-field of the hippocampus [30]. CA1 pyramidal neurons
elaborate several morphologically distinct dendritic arbours onto
which excitatory and inhibitory synapses are targeted to specific
sub-cellular domains, allowing for the spatial segregation of
information flow from diverse cell-types; see [21,35] for review.
This compartmentalisation of functionally distinct synaptic inputs
onto precise sub-cellular domains of individual pyramidal neurons
allows for the integration of excitatory and inhibitory synaptic
transmission. Therefore, the altered distribution of NL2 immuno-
reactivity, and presumably inhibitory synapses, within the CA1
region of the hippocampus in dystrophin-deficient mice suggests a
role for dystrophin in the correct patterning of GABAergic
synapses on specific sub-cellular domains of CA1 pyramidal
neurons. Its precise role is unclear but is likely to involve pre-and
postsynaptic signalling since we show mirrored changes in the
projection patterns of neurochemicals which are expressed by
defined classes of interneurons. NLs, together with neurexins, are
transynaptic adhesion molecules [52,53]. NLs are required for
correct synapse maturation but not for the initial formation of
synaptic contacts [33]. Since dystroglycan, a member of the DAP
complex which is required for the localisation of dystrophin to
GABAAR clusters, is also the physiological ligand for neurexins
[19] it is conceivable that the absence of dystrophin impairs the
ability of NLs and neurexins to initiate the maturation of
appropriate pre- and postsynaptic membranes amongst the many
redundant immature synapses formed during development. This
potential role of dystrophin in synapse maturation appears to be
restricted to specific cell-types. For example, CB1-VGLUT3-
expressing varicosities which arise predominantly from the CCK-
expressing basket cells were distributed relatively evenly across
dendritic fields in dystrophin-deficient mice (Figures 3, 4) as
opposed to their characteristic enrichment within the cell body
layer in WT mice [38]. Intriguingly, there were no apparent
changes in the level of immunoreactivity for PV-expressing
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varicosities within stratum pyramidale although increased PV
signal, together with that of somatostatin, was evident in dendritic
layers. Such increased PV-somatostatin expression could represent
alterations in bistratified cells, a class of interneuron which
preferentially targets the dendritic domains of pyramidal neurons.
However, the precise mechanisms which underlie this cell-type
selectivity of dystrophin in influencing interneuron projection
patterns are currently unclear. Likely factors could be the
developmental onset of dystrophin expression within the hippo-
campus, the developmental origins of various interneuron types
and the time course of hippocampal invasion by such cells.
Dystrophin expression within the mouse CNS commences from
embryonic day 14 onwards [54] which closely correlates with the
onset of interneuron invasion of the hippocampus [55]. However,
CCK-expressing cells are generated later and from the caudal
ganglionic eminence compared to PV-expressing cells which
originate from the medial ganglionic eminence [55]. A further
factor is likely to be the initial pattern of synapses formed during
development. CCK-expressing basket cells, prior to providing
inhibitory input onto pyramidal cells somata in adulthood, initially
form synapses on pyramidal cell dendrites during early postnatal
stages where they are postulated to provide GABA-mediated
depolarising input to augment immature glutamatergic synaptic
transmission [56]. It is currently unclear whether such initial
dendritic innervation occurs with PV-expressing basket cells due to
the low levels of PV expression during development [57,58].
Nevertheless, it is tempting to speculate that the absence of
dystrophin impacts on the relocation of these initial synaptic
contacts from dendritic compartments to their eventual somatic
locations, as evidenced by the paucity of NL2 immunoreactivity in
the pyramidal cell body layer of dystrophin-deficient mouse
models together with abnormal levels of expression in dendritic
layers. As such, this suggests a seminal role for dystrophin in the
proper functioning of NL-neurexin synapse maturation pathways.
Alterations in the projection patterns of interneurons
Functionally distinct classes of interneurons shape the patterns
of activity of principal neurons within the cortex [21,35]. They
achieve this by releasing GABA to precise sub-cellular domains of
the principal cells in defined amounts at appropriate times in a
brain state [43] and behaviour-dependent manner [59]. There-
fore, an imbalance to the rhythmicity orchestrated by the different
classes of interneurons within the brain region is likely to be the
functional consequences of the anatomical data showing an altered
distribution of VGAT, CB1, VGLUT3 and somatostatin-express-
ing varicosities in the CA1 sub-field of dystrophin-deficient mice.
For example, PV and CCK-expressing basket cells both provide
inhibitory input on the somata of hippocampal pyramidal neurons
yet occupy distinct roles in terms of different hippocampal network
oscillations [60]. Since CB1-VGLUT3 are expressed by CCK-
containing basket cells, their decreased density in immunoreactiv-
ity in stratum pyramidale could represent a decreased CCK basket
cell influence onto the cell bodies of pyramidal neurons. If so, this
imbalance of inhibitory input within this domain could have a
profound influence on the firing patterns of pyramidal neurons.
This decreased inhibitory influence from CCK-expressing basket
cell could be compensated for by the inhibitory tone of PV-
expressing basket cells. However, it is not only the release of
GABA, but also the amount released within a specific time frame
that signifies the role of a specific interneuron with a network.
Defining differences between PV and CCK-expressing basket cells
are their firing rates [61], the ultrastructure of their synaptic inputs
onto pyramidal cell somata [62] and their contributions to
entraining the activity of specific subsets of pyramidal neurons
[60]. It is this firing of subsets of pyramidal cells during different
behavioural states that underlies the role of the hippocampus in
different cognitive processes [63]. Thus, these anatomical data
demonstrate the potential alterations in the molecular machinery
that underpins pyramidal cell excitability, ushering in a potentially
novel role of dystrophin in patterning the formation of specific
subsets of synapses in addition to its well established role in
anchoring neurotransmitter receptors [14].
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